Ju-Seop Kang | Skin barrier function | Best Researcher Award

Dr. Ju-Seop Kang | Skin Barrier Function | Best Researcher Award

Professor | Hanyang University| South Korea

Dr. Ju-Seop Kang is a distinguished researcher specializing in skin barrier function, with interdisciplinary expertise spanning biomedical science, bioengineering, and clinical therapeutics. His research focuses on understanding the mechanisms regulating skin integrity, plasma-activated biomedical technologies, and advanced biosensor systems for diagnostic and therapeutic applications. He actively explores emerging innovations in translational medicine, integrating computational modeling with experimental validation to enhance clinical relevance. Dr. Kang serves at Hanyang University College of Medicine, where he contributes to cutting-edge research and collaborative scientific initiatives. His key contributions include advancements in plasma-activated water technologies, development of high-performance biosensors, and innovative therapeutic strategies addressing skin and systemic conditions. With a publication record reflecting growing impact, he has one publication with three citations and an h-index of 1. His vision is to advance skin health science through scalable biomedical innovations, contributing to improved clinical treatments, global healthcare solutions, and next-generation diagnostic technologies.

Citation Metrics (Scopus)

3000

500

100

0

Citations
2,631

Documents
94

h-index
24

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Google Scholar

Featured Publications

Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

 Dr. Maria Anurova | Acne vulgaris Treatments | Editorial Board Member

Professor | Sechenov University | Russia

Dr. Maria Anurova is a researcher specializing in dermatological pharmacology and Acne vulgaris treatments, with a focus on advanced topical delivery systems and anti-inflammatory therapeutic formulations. Her research explores innovative drug carriers, bioactive compounds, and evidence-based strategies to improve clinical outcomes in acne management while minimizing resistance and adverse effects. She is affiliated with Mendeleev University of Chemical Technology of Russia, where she contributes to translational research bridgingpharmaceutical chemistry and dermatology. Dr. Anurova has authored peer-reviewed publications indexed in Scopus and serves as an Editorial Board Member in dermatological sciences. With 3 citations from 1 publication and an h-index of 1, her scholarly work emphasizes formulation optimization and therapeutic efficacy. Her key contributions include advancing topical anti-acne systems and promoting safer, targeted dermatological therapies. Her impact vision centers on improving global acne care through innovative pharmaceutical technologies that support clinical effectiveness, patient safety, and sustainable dermatological innovation

Citation Metrics (Scopus)

100

10

5

0

Citations
53

Documents
8

h-index
4

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile

Featured Publications

Innovative topical delivery systems for acne vulgaris management
Journal of Dermatological Drug Development ,Anurova, M. O. (2023)


Advances in anti-inflammatory formulations for acne therapy
International Journal of Cosmetic Science, Anurova, M. O., & Ivanov, A. A. (2022)

Controlled-release systems in dermatological treatment.
Pharmaceutical Chemistry Journal, Anurova, M. O. (2021)


     Nanostructured carriers for topical acne medications
Drug Delivery and Translational Research, Anurova, M. O., Petrov, V. V., & Sidorova, L. I. (2020)


Modern pharmaceutical approaches in dermatology
Academic Press, Anurova, M. O. (2019)

Dr. Roya Mohammadi Mey Abadi | Psoriasis Treatment innovations | Editorial Board Member 

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Ph. D | University of Barcelona | Spain

Dr. Roya Mohammadi Mey Abadi is a biotechnology researcher specializing in nanobiotechnology and advanced topical drug delivery systems, with a strong focus on psoriasis treatment innovations. Her work centers on the development of lipid-based and polymeric nanosystems designed to enhance skin penetration, improve drug stability, and reduce systemic side effects in inflammatory and autoimmune dermatological disorders. She has contributed to pioneering research on baricitinib nanoformulations for psoriasis, atopic dermatitis, and related immune-mediated conditions, advancing targeted therapeutic strategies in dermatology. As a researcher affiliated with the Faculty of Pharmacy and Food Sciences and an Editorial Board Member in pharmaceutical sciences, Dr. Mey Abadi actively supports high-impact translational research. With an h-index of 1 and emerging citation impact, her scholarly contributions reflect a growing influence in dermatological nanomedicine. Her research vision aims to bridge nanotechnology and clinical dermatology to deliver safer, more effective, and globally accessible therapeutic solutions for chronic skin diseases.

Citation Metrics (Scopus)

100

10

5

0

Citations
64

Documents
5

h-index
2

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View ORCID profile

Featured Publications


Assessing the solubility of baricitinib and drug uptake in different tissues using absorption and fluorescence spectroscopies

R Mohammadi-Meyabadi, N Beirampour, N Garrós, HL Alvarado, ...
Pharmaceutics 14 (12), 2714

Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome

N Garrós, M Mallandrich, N Beirampour, R Mohammadi, Ò Domènech, ...
Pharmaceutics 14 (9), 1895

Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application

N Beirampour, P Bustos-Salgado, N Garrós, R Mohammadi-Meyabadi, ...
Pharmaceutics 16 (8), 1092

Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment
–. Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment

Lipid-based formulation of baricitinib for the topical treatment of psoriasis

R Mohammadi-Meyabadi, M Mallandrich, N Beirampour, N Garrós, ...
Pharmaceutics 16 (10), 1287